Haemonetics (NYSE:HAE), headquartered in Braintree, Massachusetts, specializes in blood management solutions that support the collection, processing and transfusion of blood and blood components. The company’s portfolio includes apheresis systems, blood recovery devices, hemostasis monitoring products and a suite of software tools designed to enhance patient safety and operational efficiency. Haemonetics serves hospitals, blood banks and plasma collection facilities by delivering consumables, disposables and integrated information platforms that streamline workflows and ensure regulatory compliance.
Founded in 1971, Haemonetics has grown through a combination of in-house innovation and targeted acquisitions. Early milestones in plasma separation technologies set the stage for subsequent developments in automated blood processing and real-time data analytics. Over the decades, the company has expanded its capabilities via strategic purchases of complementary businesses, strengthening its position in transfusion medicine, surgical blood salvage and patient blood management.
With operations spanning more than 100 countries, Haemonetics maintains manufacturing and research facilities in North America, Europe and Asia Pacific. This global footprint enables the company to provide localized customer support, rapid delivery of critical supplies and adherence to regional regulatory requirements. Its software platforms offer inventory tracking, quality control and reporting functions, helping clients optimize inventory levels, reduce waste and improve clinical outcomes.
Under the leadership of President and Chief Executive Officer Tim S. Ring, Haemonetics continues to invest in research and development to address evolving needs in healthcare. The executive team’s combined expertise in medical technology, operations and global markets drives the company’s commitment to advancing patient blood management. By focusing on innovation, service and collaboration, Haemonetics aims to deliver solutions that enhance transfusion safety and operational performance for healthcare providers worldwide.
